Suppr超能文献

比较各种包膜蛋白将慢病毒载体假型化并转导人血中原始造血细胞的能力。

Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.

作者信息

Hanawa Hideki, Kelly Patrick F, Nathwani Amit C, Persons Derek A, Vandergriff Jody A, Hargrove Phillip, Vanin Elio F, Nienhuis Arthur W

机构信息

Department of Hematology/Oncology, Division of Experimental Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

出版信息

Mol Ther. 2002 Mar;5(3):242-51. doi: 10.1006/mthe.2002.0549.

Abstract

Substantial effort has been invested in developing methodologies for efficient gene transfer into human, repopulating, hematopoietic stem cells. Oncoretroviral vectors are limited by the lack of nuclear mitosis in quiescent stem cells during ex vivo transduction, whereas the preintegration complex of lentiviral vectors contains nuclear-localizing signals that permit genome integration without mitosis. We have developed a flexible and versatile system for generating lentiviral vector particles and have pseudotyped such particles with amphotropic, ecotropic, feline endogenous virus (RD114) or vesicular stomatitis virus (VSV-G) envelope proteins. Particles of all four types could be concentrated approximately 100-fold by ultracentrifugation or ultrafiltration. RD114 or amphotropic particles were more efficient than VSV-G-pseudotyped particles at transducing human cord blood CD34(+) cells and clonogenic progenitors within that population. Amphotropic particles transduced cytokine-mobilized, human peripheral blood CD34(+) cells capable of establishing hematopoiesis in immunodeficient mice more efficiently than the other two types of particles. We conclude that the use of amphotropic pseudotyped lentiviral vector particles rather than the commonly used VSV-G-pseudotyped particles should be considered in potential applications of lentiviral vectors for gene transfer into this therapeutically relevant target cell population.

摘要

在开发将基因有效导入人类再殖造血干细胞的方法上已经投入了大量努力。逆转录病毒载体受限于体外转导过程中静止干细胞缺乏核有丝分裂,而慢病毒载体的前整合复合体包含核定位信号,允许基因组在无有丝分裂的情况下整合。我们已经开发了一种灵活通用的系统来产生慢病毒载体颗粒,并用嗜异性、嗜亲性、猫内源性病毒(RD114)或水泡性口炎病毒(VSV-G)包膜蛋白对这些颗粒进行了假型化。通过超速离心或超滤,所有四种类型的颗粒都可以浓缩约100倍。在转导人脐带血CD34(+)细胞和该群体中的克隆形成祖细胞方面,RD114或嗜异性颗粒比VSV-G假型化颗粒更有效。嗜异性颗粒比其他两种类型的颗粒更有效地转导能够在免疫缺陷小鼠中建立造血功能的细胞因子动员的人外周血CD34(+)细胞。我们得出结论,在慢病毒载体用于将基因导入这个具有治疗相关性的靶细胞群体的潜在应用中,应考虑使用嗜异性假型化慢病毒载体颗粒而非常用的VSV-G假型化颗粒。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验